Marshall Wace’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302K | Buy |
26,779
+729
| +3% | +$8.21K | ﹤0.01% | 2185 |
|
|
2025
Q1 | $247K | Sell |
26,050
-68,270
| -72% | -$647K | ﹤0.01% | 2207 |
|
|
2024
Q4 | $1.06M | Buy |
94,320
+29,328
| +45% | +$330K | ﹤0.01% | 1585 |
|
|
2024
Q3 | $1.84M | Buy |
64,992
+584
| +0.9% | +$16.5K | ﹤0.01% | 1293 |
|
|
2024
Q2 | $1.23M | Buy |
+64,408
| New | +$1.23M | ﹤0.01% | 1447 |
|
|
2023
Q1 | – | Sell |
-81,950
| Closed | -$2.3M | – | 2267 |
|
|
2022
Q4 | $2.3M | Sell |
81,950
-281,790
| -77% | -$7.91M | 0.01% | 1307 |
|
|
2022
Q3 | $13.1M | Sell |
363,740
-59,995
| -14% | -$2.16M | 0.03% | 611 |
|
|
2022
Q2 | $13M | Buy |
423,735
+59,705
| +16% | +$1.83M | 0.03% | 633 |
|
|
2022
Q1 | $11.8M | Buy |
364,030
+134,134
| +58% | +$4.33M | 0.02% | 724 |
|
|
2021
Q4 | $6.36M | Buy |
229,896
+187,347
| +440% | +$5.18M | 0.01% | 1074 |
|
|
2021
Q3 | $1.32M | Buy |
+42,549
| New | +$1.32M | 0.01% | 1422 |
|
|
2019
Q4 | – | Sell |
-419,855
| Closed | -$3.02M | – | 1745 |
|
|
2019
Q3 | $3.02M | Sell |
419,855
-1,193,417
| -74% | -$8.58M | 0.02% | 609 |
|
|
2019
Q2 | $12.8M | Buy |
1,613,272
+844,888
| +110% | +$6.72M | 0.11% | 210 |
|
|
2019
Q1 | $9.67M | Buy |
+768,384
| New | +$9.67M | 0.09% | 268 |
|
|
2018
Q3 | – | Sell |
-52,623
| Closed | -$1.11M | – | 1172 |
|
|
2018
Q2 | $1.11M | Buy |
+52,623
| New | +$1.11M | 0.02% | 497 |
|
|
2016
Q4 | – | Sell |
-80,099
| Closed | -$1.97M | – | 1006 |
|
|
2016
Q3 | $1.97M | Buy |
+80,099
| New | +$1.97M | 0.01% | 598 |
|